Breaking News Headlines Today | Ground News

See every side of every news story

WDEL 101.7FM image

News from WDEL 101.7FM

Wilmington, United States

The Ground News media bias check for WDEL 101.7FM is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

WDEL 101.7FM’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about WDEL 101.7FM

Where is WDEL 101.7FM located?Wilmington, United StatesWDEL 101.7FM's Website WDEL 101.7FM's Twitter WDEL 101.7FM's Wikipedia

Media Bias Ratings

Average Bias Rating:

Center

Center

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top WDEL 101.7FM News

D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025

D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025

61% Center coverage: 67 sources

PALO ALTO, Calif.--(BUSINESS WIRE)--Oct 23, 2025-See the Story

Ashburn, Virginia · Ashburn

DXC Appoints Anthony Pappas as Chief Marketing Officer to Lead Next Phase of Brand Transformation

56% Center coverage: 43 sources

ASHBURN, Va., Oct. 23, 2025 /PRNewswire/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Anthony Pappas as Chief Marketing Officer, reporting directly to President and CEO Raul Fernandez.See the Story

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease

Alzheimer's Disease · Taiwan

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease

58% Center coverage: 42 sources

TAIPEI, Oct. 22, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and bulbar muscular atrophy…See the Story

Breaking News Topics Related to WDEL 101.7FM